*Disclaimers:

The Cue website may depict certain of our future planned care offerings which are subject to completion of development and may require regulatory authorization, clearance, or approval before they can be commercialized.

Cue Care^TM includes a virtual care visit with a qualified healthcare provider who will help determine whether a prescription or treatment referral is right for you. This service does not address life-threatening conditions. In case of an emergency, please call 911. See the Cue Care Terms of Use at cuehealth.com/docs. Medication requires prescription and is subject to availability and patient eligibility. Cost includes virtual care session and medication delivery only. Cost of medication is not included. Exceptions to same-day delivery may apply. Cue Health Inc. is not affiliated with any pharmaceutical manufacturer.

Cue Care included at no additional cost with purchase of applicable Cue test or test kit. Available only through the Cue Health App. For further details read here.

Cue Care COVID-19 treatment services are available only to individuals 12 years or older who recently tested positive for COVID-19. For minor children (ages 12-17), a parent or guardian with a Cue Health account who is authorized to consent on behalf of the child must be present.

You must be age 18 or older to use Cue’s at-home test kits. Some tests are restricted by sex assigned at birth. Due to state restrictions, Cue's at-home test kits are not available to residents of New York. Other restrictions may apply to at-home test kits and to Cue Care treatment services for some tests. Check your specific test for eligibility requirements.

Cue’s COVID-19 test has not been FDA cleared or approved; but has been authorized by FDA under an EUA. This product has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

For more disclaimers read here.